CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

May 9, 2023 · earnings

ENTA earnings: a negative outcome, -25.7%

On May 9, 2023, Enanta Pharmaceuticals, Inc. reached its earnings. The result was a negative outcome, and the stock moved -25.7% in the window around the event. It had already run -9.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$34.33
1d before
$25.52
Event day
$26.51
1d after
$25.33
5d after

Pre-catalyst setup

-9.6%
30-day run-up
5112%
30-day volatility
1.2×
volume spike